Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022

Provided By Globe Newswire

Last update: Jan 26, 2023

BASEL, Switzerland, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a biopharmaceutical company that aspires to redefine care for women and men through purpose-driven science, empowering medicines, and transformative advocacy, today announced financial results for the third quarter of fiscal year 2022 and provided other corporate updates.